SAN DIEGO--(BUSINESS WIRE)--Orexigen® Therapeutics, Inc. (Nasdaq:OREX), a biopharmaceutical company focused on the treatment of central nervous system disorders, including obesity, will announce its first quarter 2008 financial results on Thursday, May 8, 2008 after the markets close. The announcement will be followed by a live conference call and webcast at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). The Orexigen management team will host the call and webcast to discuss first quarter 2008 financial results and recent business highlights.
